Latest filing published 14 Nov 2023 for Tabula Rasa HealthCare, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael Greenhalgh is a declared insider of Tabula Rasa HealthCare, Inc. (senior executive), with filings sourced from SEC (Form 4). In total, 11 filings cover trades dated from 2 June 2021 to 3 November 2023.
Both buying and selling appear: 1 purchase worth €10k, against 4 sales worth €132k. Netting one side against the other leaves €122k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants and 3 option exercises.
Most recently, on 14 November 2023, the filings show a transaction in Tabula Rasa HealthCare, Inc. The last insider purchase was made public on 4 March 2022, 1,689 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations